Published in Ann Intern Med on February 05, 2008
The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care (2009) 2.10
Colorectal cancer knowledge is not associated with screening compliance or intention. J Cancer Educ (2009) 0.89
A randomized comparison of print and web communication on colorectal cancer screening. JAMA Intern Med (2013) 0.87
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med (2014) 2.89
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Management of bleeding GI tumors. Gastrointest Endosc (2010) 1.79
Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol (2010) 1.69
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res (2011) 1.59
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res (2012) 1.53
Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med (2009) 1.41
Proteomic analyses of pancreatic cyst fluids. Pancreas (2009) 1.29
Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol (2003) 1.28
Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA (2009) 1.21
Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev (2007) 1.16
Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn (2005) 1.07
Using the interdependence model to understand spousal influence on colorectal cancer screening intentions: a structural equation model. Ann Behav Med (2012) 1.03
Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes Control (2009) 1.00
Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.00
Build it, and will they come? Unexpected findings from a study on a Web-based intervention to improve colorectal cancer screening. J Health Commun (2011) 0.98
A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: trial design and baseline findings. Contemp Clin Trials (2010) 0.91
Molecular staging individualizing cancer management. J Surg Oncol (2012) 0.90
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2011) 0.89
Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev (2011) 0.85
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 0.84
A qualitative analysis of couples' communication regarding colorectal cancer screening using the Interdependence Model. Patient Educ Couns (2011) 0.84
Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer. J Surg Oncol (2012) 0.83
Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: a pilot study. Genet Med (2007) 0.83
In the clinic. Screening for colorectal cancer. Ann Intern Med (2014) 0.83
Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer (2011) 0.81
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients. Expert Rev Mol Diagn (2009) 0.80
Colonoscopy: what does it take to get it "right"? Ann Intern Med (2011) 0.79
Molecular staging estimates occult tumor burden in colorectal cancer. Adv Clin Chem (2010) 0.79
Narrative review: screening for colorectal cancer in patients with a first-degree relative with colonic neoplasia. Ann Intern Med (2005) 0.79
Description of a new hepatitis C risk assessment tool. Arch Intern Med (2005) 0.79
Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. Semin Radiat Oncol (2007) 0.79
Large adenoma recurrence after polypectomy. Gastrointest Endosc (2009) 0.78
Evidence for DNA damage checkpoint activation in barrett esophagus. Transl Oncol (2010) 0.78
The evolving role of CT colonography. Cancer Invest (2007) 0.78
The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. Cancer Genet Cytogenet (2006) 0.77
Effectiveness of complete diagnostic examination in clinical practice settings. Cancer Detect Prev (2006) 0.77
Colorectal cancer screening: America's next top model? Ann Intern Med (2012) 0.77
Screening for colorectal cancer--now and the near future. Semin Oncol (2005) 0.76
Author reply: To PMID 23208168. Ann Intern Med (2013) 0.75
Making the case for the benefits of primary care from observational studies: does an ounce of prevention take a pound of doctor visits? Ann Intern Med (2013) 0.75
A pilot evaluation of the efficacy of a couple-tailored print intervention on colorectal cancer screening practices among non-adherent couples. Psychol Health (2013) 0.75
Update in Gastroenterology and Hepatology: Evidence Published in 2015. Ann Intern Med (2016) 0.75
How to recognize a good guideline. Gastroenterology (2013) 0.75
Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Dis Colon Rectum (2017) 0.75
Medicare physician payment data: is this transparency? Ann Intern Med (2014) 0.75
Update in gastroenterology and hepatology: evidence published in 2014. Ann Intern Med (2015) 0.75